Why the study?
Does baseline platelet function predict subsequent platelet activity at 24 hours following thrombolysis in patients with acute myocardial infarction?
Does baseline platelet function predict subsequent platelet activity at 24 hours following thrombolysis in patients with acute myocardial infarction?
Baseline platelet characteristics can predict future platelet activity after coronary thrombolysis, which may help identify AMI patients who would benefit from more aggressive antiplatelet strategies.
Answers are grounded in this paper and cite their sources.
Baseline platelet function may identify AMI patients for intensified antiplatelet therapy post-thrombolysis; hypothesis-generating and requires prospective validation.
The early identification of patients with heightened platelet activity for aggressive antiplatelet regimens represents a critical clinical issue in acute myocardial infarction (AMI) therapy. We sought to determine whether the degree of pre-reperfusion platelet function is related to subsequent activity following thrombolysis. Platelets were investigated at baseline and at 24 h following thrombolytic therapy by aggregometry, and flow cytometry in 19 AMI patients enrolled in the GUSTO-III trial. Regression analysis revealed a significant correlation for 5 microM ADP (r2 = 0.529), 10 microM ADP (r2 = 0.445), thrombin (r2 = 0.226), collagen (r2 = 0.568), and ristocetin-induced aggregation (r2 = 0.964). Platelet expression linearly correlated for GPIIb/IIIa (r2 = 0.337), P-selectin (r = 0.817), PECAM-1 (r2 = 0.586), and the vitronectin receptor (r2 = 0.634). The data suggest that the baseline characteristics predict future platelet activity, and may prospectively identify patients who will benefit most from antiplatelet strategies after coronary thrombolysis.
No takes yet. Share an insight, caveat, or question.
Dean J. Kereiakes Paul A. Gurbel (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: